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Abstract
Background: Reduction in visual acuity combined with blurred vision is rarely the first sign of lung cancer and
very few cases have been announced globally.
Case presentation: A case of a 46-year-old man who admitted with blurred vision is presented. His medical
history, apart from a mild gastritis under treatment was negative. Ocular examination revealed a decrease in visual
acuity due to a choroidal tumor. Further image body scans demonstrated a right lung lesion with dissemination to
other organs. Diagnosis of a non-small cell lung cancer established after a VATS biopsy carried out.
Conclusion: Blurred vision due to choroidal metastasis as the primary symptom of lung cancer is very uncommon.
A great index of suspicion is essential when a choroidal lesion appears.
Background
The incidence of ocular metastases from lung cancer is
reported to be 2-7% according to the international lit-
erature [1,2]. The majority of cases involves end-stage
patients. Choroidal metastases are metastatic lesions to
the choroid layer of the eye. Decrease in optical acuity
as the initial manifestation of lung cancer is infrequent.
Case presentation
A 46-year-old man noticed, three months ago, that for
t h ep a s tt w ow e e k sh i sl e f te y es u f f e r e df r o mr e d u c t i o n
in vision with a concomitant blurredness. He had no
medical history apart from a mild gastritis under treat-
ment. He was a heavy smoker (one and a half pack of
cigarettes for the last 27 years), while he was a social
drinker. Examination showed visual acuity of 2/20 in the
left eye and normal in the right eye. Fundus examina-
tion revealed the presence of a choroidal tumor located
superior to the optic nerve measuring 921 mm (Fig 1).
An ultrasonographic evaluation of the eye demonstrated
that the tumor had a height of 1.8 mm (Fig 2). Com-
puted tomography of the chest, abdomen and brain
were performed. A central lesion of the right upper lobe
of the lung was detected. Both, a small pleural effusion
and several mediastinal enlarged lymph nodes were
accompanying the aforementioned lesion. Moreover,
small, bilateral adrenal masses were also present, while
three brain metastases appeared. A bone scanning
revealed multiple lesions.
A transthoracic needle biopsy of the right upper lobe
lung mass could not provide enough material to estab-
lish an accurate histopathological diagnosis. The patient
experienced a Video Assisted Thoracic Surgical biopsy
and the diagnosis of a low-grade squamous cell carci-
noma was established (Fig 3). He was discharged after 5
days. The patient is currently receiving chemotherapy
and radiotherapy.
Discussion
The highly vascular uveal tract is the most common part
of the eye involved by metastases. Within the uvea, the
choroid (88%) is the most commonly affected site fol-
lowed by the iris (9%) and ciliary body (2%) [3]. Breast
cancer seems to be the most frequent type of cancer giv-
ing intraocular metastases. The incidence for the breast
cancer is reported to be 37-41%, while lung cancer is
considered to be responsible for no more than 7% of
choroidal metastases [4,5]. It is generally considered that
these kind of metastatic lesions occur at the final stage of
the disease, where the mean survival is not expected to
be more than 6 months and the majority of the patients
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any medium, provided the original work is properly cited.Figure 1 Left ocular fundus photo composite shows superior solitary choroidal metastase (black arrows).
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The reason for this unusual site to be target for second-
ary metastases from lung cancer is generally unknown. It
is, however, speculated that its high vascularity may con-
sist a reasonable explanation [7]. The diagnosis of ocular
metastases is based primarily on clinical findings supple-
mented by imaging studies. The diagnostic procedures
include ultrasonography, fluorescein angiography, com-
puted tomography/MRI, fine-needle aspiration, or wedge
biopsy. Brain imaging is useful before initiation of radio-
therapy to assist in treatment planning. It is reported that
22% of patients diagnosed with choroidal metastasis had
a concurrent diagnosis of central nervous system metas-
tasis [8]. Differential diagnosis includes primary choroidal
melanomas, benign lesions such as haemangioma, and
inflammatory granulomas.
Decrease in vision and blurredness as the initial mani-
festation of lung carcinoma is therefore very rare. A
review of the literature brought to light 12 cases of lung
cancer patients suffering from choroidal metastases as
the primary clinical sign. In all cases, the diagnosis of
the choroidal metastases declares final stage disease and
the dissemination seems to be almost certain. Prognosis
is poor and life expectancy short.
Treatment for ocular metastases is palliative because
the presence of such metastases suggests hematogenous
spread of cancer. In line with this, the aims for treat-
ment are to maximize quality of life, and restore or pre-
serve vision. This may be achieved with either
radiotherapy or chemotherapy. Surgery has not played
an important role other than diagnostic biopsy, as sur-
gery carries great potential morbidity and often there is
no need for tumor debulking.
Conclusions
In conclusion, when a choroidal lesion is discovered, the
differential diagnosis should include secondary metastases
due to malignant tumors originated from distal organs.
Figure 2 Transverse B-scan ultrasound of superior posterior pole, left eye, shows choroidal mass (red arrows).
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Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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